Matinas Biopharma Holdings, Inc. stockholders approved a reduction of authorized shares from 500 million to 250 million and a reverse stock split at a ratio of 1-for-50, effective August 30, 2024.
AI Assistant
MATINAS BIOPHARMA HOLDINGS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.